Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 549 entries
Sorted by: Best Match Show Resources per page
Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea.

Infection & chemotherapy

Kim J, Seo MR, Kang JO, Choi TY, Pai H.
PMID: 24265965
Infect Chemother. 2013 Jun;45(2):175-83. doi: 10.3947/ic.2013.45.2.175. Epub 2013 Jun 26.

BACKGROUND: Binary toxin-producing Clostridium difficile infections (CDI) are known to be more severe and to cause higher case fatality rates than those by binary toxin-negative isolates. There has been few data of binary toxin-producing CDI in Korea. Objective of...

Cite
Kim J, Seo MR, Kang JO, et al. Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea. Infect Chemother. 2013;45(2):175-83doi: 10.3947/ic.2013.45.2.175.
Kim, J., Seo, M. R., Kang, J. O., Choi, T. Y., & Pai, H. (2013). Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea. Infection & chemotherapy, 45(2), 175-83. https://doi.org/10.3947/ic.2013.45.2.175
Kim, Jieun, et al. "Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea." Infection & chemotherapy vol. 45,2 (2013): 175-83. doi: https://doi.org/10.3947/ic.2013.45.2.175
Kim J, Seo MR, Kang JO, Choi TY, Pai H. Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea. Infect Chemother. 2013 Jun;45(2):175-83. doi: 10.3947/ic.2013.45.2.175. Epub 2013 Jun 26. PMID: 24265965; PMCID: PMC3780953.
Copy Download .nbib Format: NLM
Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey.

Antimicrobial resistance and infection control

Parascandalo FA, Zarb P, Tartari E, Lacej D, Bitincka S, Manastirliu O, Nika D, Borg MA.
PMID: 27499852
Antimicrob Resist Infect Control. 2016 Aug 05;5:29. doi: 10.1186/s13756-016-0128-1. eCollection 2016.

BACKGROUND: Antimicrobial resistance has been recognised as a serious global Public Health problem. Prevalence of Multiple-Drug-Resistant (MDR) organism carriage in Albania is largely unknown since no national surveillance system is in place and few publications are accessible in the...

Cite
Parascandalo FA, Zarb P, Tartari E, et al. Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey. Antimicrob Resist Infect Control. 2016;5:29doi: 10.1186/s13756-016-0128-1.
Parascandalo, F. A., Zarb, P., Tartari, E., Lacej, D., Bitincka, S., Manastirliu, O., Nika, D., & Borg, M. A. (2016). Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey. Antimicrobial resistance and infection control, 529. https://doi.org/10.1186/s13756-016-0128-1
Parascandalo, Falzon A, et al. "Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey." Antimicrobial resistance and infection control vol. 5 (2016): 29. doi: https://doi.org/10.1186/s13756-016-0128-1
Parascandalo FA, Zarb P, Tartari E, Lacej D, Bitincka S, Manastirliu O, Nika D, Borg MA. Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey. Antimicrob Resist Infect Control. 2016 Aug 05;5:29. doi: 10.1186/s13756-016-0128-1. eCollection 2016. PMID: 27499852; PMCID: PMC4975909.
Copy Download .nbib Format: NLM
Mass spectrometry-based analyses showing the effects of secretor and blood group status on salivary N-glycosylation.

Clinical proteomics

Albertolle ME, Hassis ME, Ng CJ, Cuison S, Williams K, Prakobphol A, Dykstra AB, Hall SC, Niles RK, Ewa Witkowska H, Fisher SJ.
PMID: 26719750
Clin Proteomics. 2015 Dec 30;12:29. doi: 10.1186/s12014-015-9100-y. eCollection 2015.

BACKGROUND: The carbohydrate portions of salivary glycoproteins play important roles, including mediating bacterial and leukocyte adhesion. Salivary glycosylation is complex. Many of its glycoproteins present ABO and Lewis blood group determinants. An individual's genetic complement and secretor status govern...

Cite
Albertolle ME, Hassis ME, Ng CJ, et al. Mass spectrometry-based analyses showing the effects of secretor and blood group status on salivary N-glycosylation. Clin Proteomics. 2015;12:29doi: 10.1186/s12014-015-9100-y.
Albertolle, M. E., Hassis, M. E., Ng, C. J., Cuison, S., Williams, K., Prakobphol, A., Dykstra, A. B., Hall, S. C., Niles, R. K., Ewa Witkowska, H., & Fisher, S. J. (2015). Mass spectrometry-based analyses showing the effects of secretor and blood group status on salivary N-glycosylation. Clinical proteomics, 1229. https://doi.org/10.1186/s12014-015-9100-y
Albertolle, Matthew E, et al. "Mass spectrometry-based analyses showing the effects of secretor and blood group status on salivary N-glycosylation." Clinical proteomics vol. 12 (2015): 29. doi: https://doi.org/10.1186/s12014-015-9100-y
Albertolle ME, Hassis ME, Ng CJ, Cuison S, Williams K, Prakobphol A, Dykstra AB, Hall SC, Niles RK, Ewa Witkowska H, Fisher SJ. Mass spectrometry-based analyses showing the effects of secretor and blood group status on salivary N-glycosylation. Clin Proteomics. 2015 Dec 30;12:29. doi: 10.1186/s12014-015-9100-y. eCollection 2015. PMID: 26719750; PMCID: PMC4696288.
Copy Download .nbib Format: NLM
Detection of glycopeptide resistance genes in enterococci by multiplex PCR.

Medical journal, Armed Forces India

Bhatt P, Sahni AK, Praharaj AK, Grover N, Kumar M, Chaudhari CN, Khajuria A.
PMID: 25609863
Med J Armed Forces India. 2015 Jan;71(1):43-7. doi: 10.1016/j.mjafi.2014.03.005. Epub 2014 Jun 07.

BACKGROUND: Vancomycin Resistant Enterococci (VRE) are a major cause of nosocomial infections. There are various phenotypic and genotypic methods of detection of glycopeptide resistance in enterococci. This study utilizes multiplex PCR for reliable detection of various glycopeptides resistance genes...

Cite
Bhatt P, Sahni AK, Praharaj AK, et al. Detection of glycopeptide resistance genes in enterococci by multiplex PCR. Med J Armed Forces India. 2014;71(1):43-7doi: 10.1016/j.mjafi.2014.03.005.
Bhatt, P., Sahni, A. K., Praharaj, A. K., Grover, N., Kumar, M., Chaudhari, C. N., & Khajuria, A. (2015). Detection of glycopeptide resistance genes in enterococci by multiplex PCR. Medical journal, Armed Forces India, 71(1), 43-7. https://doi.org/10.1016/j.mjafi.2014.03.005
Bhatt, Puneet, et al. "Detection of glycopeptide resistance genes in enterococci by multiplex PCR." Medical journal, Armed Forces India vol. 71,1 (2015): 43-7. doi: https://doi.org/10.1016/j.mjafi.2014.03.005
Bhatt P, Sahni AK, Praharaj AK, Grover N, Kumar M, Chaudhari CN, Khajuria A. Detection of glycopeptide resistance genes in enterococci by multiplex PCR. Med J Armed Forces India. 2015 Jan;71(1):43-7. doi: 10.1016/j.mjafi.2014.03.005. Epub 2014 Jun 07. PMID: 25609863; PMCID: PMC4297841.
Copy Download .nbib Format: NLM
Aminoglycoside-Induced Cochleotoxicity: A Review.

Frontiers in cellular neuroscience

Jiang M, Karasawa T, Steyger PS.
PMID: 29062271
Front Cell Neurosci. 2017 Oct 09;11:308. doi: 10.3389/fncel.2017.00308. eCollection 2017.

Aminoglycoside antibiotics are used as prophylaxis, or urgent treatment, for many life-threatening bacterial infections, including tuberculosis, sepsis, respiratory infections in cystic fibrosis, complex urinary tract infections and endocarditis. Although aminoglycosides are clinically-essential antibiotics, the mechanisms underlying their selective toxicity...

Cite
Jiang M, Karasawa T, Steyger PS. Aminoglycoside-Induced Cochleotoxicity: A Review. Front Cell Neurosci. 2017;11:308doi: 10.3389/fncel.2017.00308.
Jiang, M., Karasawa, T., & Steyger, P. S. (2017). Aminoglycoside-Induced Cochleotoxicity: A Review. Frontiers in cellular neuroscience, 11308. https://doi.org/10.3389/fncel.2017.00308
Jiang, Meiyan, et al. "Aminoglycoside-Induced Cochleotoxicity: A Review." Frontiers in cellular neuroscience vol. 11 (2017): 308. doi: https://doi.org/10.3389/fncel.2017.00308
Jiang M, Karasawa T, Steyger PS. Aminoglycoside-Induced Cochleotoxicity: A Review. Front Cell Neurosci. 2017 Oct 09;11:308. doi: 10.3389/fncel.2017.00308. eCollection 2017. PMID: 29062271; PMCID: PMC5640705.
Copy Download .nbib Format: NLM
Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant .

Frontiers in microbiology

Tang HJ, Lai CC, Chen CC, Zhang CC, Weng TC, Yu WL, Chen HJ, Chiu YH, Ko WC, Chuang YC.
PMID: 28572795
Front Microbiol. 2017 May 18;8:884. doi: 10.3389/fmicb.2017.00884. eCollection 2017.

The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of

Cite
Tang HJ, Lai CC, Chen CC, et al. Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant . Front Microbiol. 2017;8:884doi: 10.3389/fmicb.2017.00884.
Tang, H. J., Lai, C. C., Chen, C. C., Zhang, C. C., Weng, T. C., Yu, W. L., Chen, H. J., Chiu, Y. H., Ko, W. C., & Chuang, Y. C. (2017). Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant . Frontiers in microbiology, 8884. https://doi.org/10.3389/fmicb.2017.00884
Tang, Hung-Jen, et al. "Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant ." Frontiers in microbiology vol. 8 (2017): 884. doi: https://doi.org/10.3389/fmicb.2017.00884
Tang HJ, Lai CC, Chen CC, Zhang CC, Weng TC, Yu WL, Chen HJ, Chiu YH, Ko WC, Chuang YC. Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant . Front Microbiol. 2017 May 18;8:884. doi: 10.3389/fmicb.2017.00884. eCollection 2017. PMID: 28572795; PMCID: PMC5435797.
Copy Download .nbib Format: NLM
Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis.

World journal of nephrology

Barretti P, Doles JV, Pinotti DG, El Dib RP.
PMID: 25949943
World J Nephrol. 2015 May 06;4(2):287-94. doi: 10.5527/wjn.v4.i2.287.

Peritonitis continues to be a major complication of peritoneal dialysis (PD), and adequate treatment is crucial for a favorable outcome. There is no consensus regarding the optimal therapeutic regimen, and few prospective controlled studies have been published. The objective...

Cite
Barretti P, Doles JV, Pinotti DG, et al. Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis. World J Nephrol. 2015;4(2):287-94doi: 10.5527/wjn.v4.i2.287.
Barretti, P., Doles, J. V., Pinotti, D. G., & El Dib, R. P. (2015). Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis. World journal of nephrology, 4(2), 287-94. https://doi.org/10.5527/wjn.v4.i2.287
Barretti, Pasqual, et al. "Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis." World journal of nephrology vol. 4,2 (2015): 287-94. doi: https://doi.org/10.5527/wjn.v4.i2.287
Barretti P, Doles JV, Pinotti DG, El Dib RP. Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis. World J Nephrol. 2015 May 06;4(2):287-94. doi: 10.5527/wjn.v4.i2.287. PMID: 25949943; PMCID: PMC4419139.
Copy Download .nbib Format: NLM
Glycoprotein conformation in plant cell walls : Circular dichroism reveals a polyproline II structure.

Planta

Homer RB, Roberts K.
PMID: 24318062
Planta. 1979 Jan;146(2):217-22. doi: 10.1007/BF00388235.

The major structural glycoprotein of the cell wall of Chlamydomonas reinhardii has a protein core, at least 50% of which is in the unusual polyproline II conformation. This has been demonstrated by examining the circular dichroism of the cell...

Cite
Homer RB, Roberts K. Glycoprotein conformation in plant cell walls : Circular dichroism reveals a polyproline II structure. Planta. 1979;146(2):217-22doi: 10.1007/BF00388235.
Homer, R. B., & Roberts, K. (1979). Glycoprotein conformation in plant cell walls : Circular dichroism reveals a polyproline II structure. Planta, 146(2), 217-22. https://doi.org/10.1007/BF00388235
Homer, R B, and Roberts, K. "Glycoprotein conformation in plant cell walls : Circular dichroism reveals a polyproline II structure." Planta vol. 146,2 (1979): 217-22. doi: https://doi.org/10.1007/BF00388235
Homer RB, Roberts K. Glycoprotein conformation in plant cell walls : Circular dichroism reveals a polyproline II structure. Planta. 1979 Jan;146(2):217-22. doi: 10.1007/BF00388235. PMID: 24318062.
Copy Download .nbib Format: NLM
Staphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 cases.

Therapeutics and clinical risk management

Zhou J, Huang H, Liu S, Yu P, Wan Q.
PMID: 26109863
Ther Clin Risk Manag. 2015 Jun 12;11:933-7. doi: 10.2147/TCRM.S84579. eCollection 2015.

BACKGROUND: To describe the incidence, clinical characteristics, and outcomes of Staphylococcus aureus bacteremia after liver transplantation and investigate the drug resistance of S. aureus to frequently used antibiotics to provide evidence for clinical prevention and therapy.MATERIALS AND METHODS: In...

Cite
Zhou J, Huang H, Liu S, et al. Staphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 cases. Ther Clin Risk Manag. 2015;11:933-7doi: 10.2147/TCRM.S84579.
Zhou, J., Huang, H., Liu, S., Yu, P., & Wan, Q. (2015). Staphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 cases. Therapeutics and clinical risk management, 11933-7. https://doi.org/10.2147/TCRM.S84579
Zhou, Jiandang, et al. "Staphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 cases." Therapeutics and clinical risk management vol. 11 (2015): 933-7. doi: https://doi.org/10.2147/TCRM.S84579
Zhou J, Huang H, Liu S, Yu P, Wan Q. Staphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 cases. Ther Clin Risk Manag. 2015 Jun 12;11:933-7. doi: 10.2147/TCRM.S84579. eCollection 2015. PMID: 26109863; PMCID: PMC4472026.
Copy Download .nbib Format: NLM
Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases.

Clinical proteomics

Kurbasic E, Sjöström M, Krogh M, Folkesson E, Grabau D, Hansson K, Rydén L, Waldemarson S, James P, Niméus E.
PMID: 25991917
Clin Proteomics. 2015 May 12;12(1):13. doi: 10.1186/s12014-015-9084-7. eCollection 2015.

BACKGROUND: Breast cancer is a very heterogeneous disease and some patients are cured by the surgical removal of the primary tumour whilst other patients suffer from metastasis and spreading of the disease, despite adjuvant therapy. A number of prognostic...

Cite
Kurbasic E, Sjöström M, Krogh M, et al. Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases. Clin Proteomics. 2015;12(1):13doi: 10.1186/s12014-015-9084-7.
Kurbasic, E., Sjöström, M., Krogh, M., Folkesson, E., Grabau, D., Hansson, K., Rydén, L., Waldemarson, S., James, P., & Niméus, E. (2015). Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases. Clinical proteomics, 12(1), 13. https://doi.org/10.1186/s12014-015-9084-7
Kurbasic, Emila, et al. "Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases." Clinical proteomics vol. 12,1 (2015): 13. doi: https://doi.org/10.1186/s12014-015-9084-7
Kurbasic E, Sjöström M, Krogh M, Folkesson E, Grabau D, Hansson K, Rydén L, Waldemarson S, James P, Niméus E. Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases. Clin Proteomics. 2015 May 12;12(1):13. doi: 10.1186/s12014-015-9084-7. eCollection 2015. PMID: 25991917; PMCID: PMC4436114.
Copy Download .nbib Format: NLM
Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain.

Frontiers in pharmacology

Varamini P, Toth I.
PMID: 24379782
Front Pharmacol. 2013 Dec 13;4:155. doi: 10.3389/fphar.2013.00155.

Endomorphins are endogenous opioid peptides that cause potent antinociception in rodent models of acute and neuropathic pain with less undesirable side effects than opioid alkaloids. However, endomorphins are poorly suited to clinical applications because of low membrane permeability and...

Cite
Varamini P, Toth I. Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain. Front Pharmacol. 2013;4:155doi: 10.3389/fphar.2013.00155.
Varamini, P., & Toth, I. (2013). Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain. Frontiers in pharmacology, 4155. https://doi.org/10.3389/fphar.2013.00155
Varamini, Pegah, and Toth, Istvan. "Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain." Frontiers in pharmacology vol. 4 (2013): 155. doi: https://doi.org/10.3389/fphar.2013.00155
Varamini P, Toth I. Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain. Front Pharmacol. 2013 Dec 13;4:155. doi: 10.3389/fphar.2013.00155. PMID: 24379782; PMCID: PMC3862115.
Copy Download .nbib Format: NLM
Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implications.

BBA clinical

Brennan SO.
PMID: 26675134
BBA Clin. 2015 Mar 04;3:221-6. doi: 10.1016/j.bbacli.2015.02.007. eCollection 2015 Jun.

BACKGROUND: Fibrinogen is an acute phase glycoprotein whose concentration increases in response to trauma. The newly synthesised protein is functionally enhanced and it is known that treatment with neuraminidase increases the rate of fibrin polymerisation. To explore this, we...

Cite
Brennan SO. Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implications. BBA Clin. 2015;3:221-6doi: 10.1016/j.bbacli.2015.02.007.
Brennan, S. O. (2015). Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implications. BBA clinical, 3221-6. https://doi.org/10.1016/j.bbacli.2015.02.007
Brennan, Stephen O. "Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implications." BBA clinical vol. 3 (2015): 221-6. doi: https://doi.org/10.1016/j.bbacli.2015.02.007
Brennan SO. Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implications. BBA Clin. 2015 Mar 04;3:221-6. doi: 10.1016/j.bbacli.2015.02.007. eCollection 2015 Jun. PMID: 26675134; PMCID: PMC4661561.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 549 entries